StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma cash

Cash and short-term investments held at the end of each period.

COSCIENS Biopharma's cash was $5.01M at Mar 31, 2026. For fiscal 2025 it was $7.31M, down 55.4% from the year before. Over ten years it grew -15.9% a year on average. The highest annual figure on record is $41.45M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.31M-55.4%
FY2024Dec 31, 2024$16.39M+145.5%
FY2023Dec 31, 2023$6.68M-34.5%
FY2022Dec 31, 2022$10.19M+65.5%
FY2021Dec 31, 2021$6.16M-74.6%
FY2020Dec 31, 2020$24.27M+209.7%
FY2019Dec 31, 2019$7.84M-46.0%
FY2018Dec 31, 2018$14.51M+86.5%
FY2017Dec 31, 2017$7.78M-64.6%
FY2016Dec 31, 2016$22.00M-46.9%
FY2015Dec 31, 2015$41.45M+18.7%
FY2014Dec 31, 2014$34.93M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$5.01M-63.6%
Q4 FY2025Dec 31, 2025$7.31M-55.4%
Q3 FY2025Sep 30, 2025$8.52M-57.4%
Q2 FY2025Jun 30, 2025$9.33M-66.4%
Q1 FY2025Mar 31, 2025$13.76M+292.4%
Q4 FY2024Dec 31, 2024$16.39M+145.5%
Q3 FY2024Sep 30, 2024$20.00M+139.1%
Q2 FY2024Jun 30, 2024$27.80M+225.7%
Q1 FY2024Mar 31, 2024$3.51M-62.3%
Q4 FY2023Dec 31, 2023$6.68M-34.5%
Q3 FY2023Sep 30, 2023$8.36M-84.5%
Q2 FY2023Jun 30, 2023$8.54M-85.3%
Q1 FY2023Mar 31, 2023$9.30M-85.4%
Q4 FY2022Dec 31, 2022$10.19M+65.5%
Q3 FY2022Sep 30, 2022$53.82M-20.9%
Q2 FY2022Jun 30, 2022$58.16M-16.8%
Q1 FY2022Mar 31, 2022$63.60M-13.3%
Q4 FY2021Dec 31, 2021$6.16M-74.6%
Q3 FY2021Sep 30, 2021$68.00M+212.7%
Q2 FY2021Jun 30, 2021$69.87M+936.2%
Q1 FY2021Mar 31, 2021$73.37M+699.1%
Q4 FY2020Dec 31, 2020$24.27M+209.7%
Q3 FY2020Sep 30, 2020$21.75M+100.2%
Q2 FY2020Jun 30, 2020$6.74M-30.4%
Q1 FY2020Mar 31, 2020$9.18M-19.2%
Q4 FY2019Dec 31, 2019$7.84M-46.0%
Q3 FY2019Sep 30, 2019$10.86M-35.3%
Q2 FY2019Jun 30, 2019$9.68M-51.5%
Q1 FY2019Mar 31, 2019$11.36M-53.7%
Q4 FY2018Dec 31, 2018$14.51M+86.5%
Q3 FY2018Sep 30, 2018$16.80M-23.6%
Q2 FY2018Jun 30, 2018$19.95M-51.9%
Q1 FY2018Mar 31, 2018$24.55M-29.7%
Q4 FY2017Dec 31, 2017$7.78M–
Q4 FY2016Dec 31, 2016$22.00M–
Q4 FY2015Dec 31, 2015$41.45M–
Q4 FY2014Dec 31, 2014$34.93M–

More COSCIENS Biopharma figures

See a number that looks wrong?